GB1297221A - - Google Patents
Info
- Publication number
- GB1297221A GB1297221A GB1297221DA GB1297221A GB 1297221 A GB1297221 A GB 1297221A GB 1297221D A GB1297221D A GB 1297221DA GB 1297221 A GB1297221 A GB 1297221A
- Authority
- GB
- United Kingdom
- Prior art keywords
- microcapsules
- excipient
- active substance
- pectin
- agar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003094 microcapsule Substances 0.000 abstract 6
- 239000013543 active substance Substances 0.000 abstract 3
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 3
- 239000001856 Ethyl cellulose Substances 0.000 abstract 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract 2
- 229920002907 Guar gum Polymers 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 235000019325 ethyl cellulose Nutrition 0.000 abstract 2
- 229920001249 ethyl cellulose Polymers 0.000 abstract 2
- 239000000665 guar gum Substances 0.000 abstract 2
- 235000010417 guar gum Nutrition 0.000 abstract 2
- 229960002154 guar gum Drugs 0.000 abstract 2
- 239000001814 pectin Substances 0.000 abstract 2
- 229920001277 pectin Polymers 0.000 abstract 2
- 235000010987 pectin Nutrition 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 abstract 1
- 229920001817 Agar Polymers 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- 241000206672 Gelidium Species 0.000 abstract 1
- 235000010419 agar Nutrition 0.000 abstract 1
- 229940072056 alginate Drugs 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- -1 analgesic Substances 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000002327 cardiovascular agent Substances 0.000 abstract 1
- 229940125692 cardiovascular agent Drugs 0.000 abstract 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/025—Applications of microcapsules not provided for in other subclasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7004199A FR2077696B1 (uk) | 1970-02-06 | 1970-02-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1297221A true GB1297221A (uk) | 1972-11-22 |
Family
ID=9050176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1297221D Expired GB1297221A (uk) | 1970-02-06 | 1971-04-19 |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE762574A (uk) |
DE (1) | DE2105110A1 (uk) |
ES (1) | ES387532A1 (uk) |
FR (1) | FR2077696B1 (uk) |
GB (1) | GB1297221A (uk) |
NL (1) | NL7101418A (uk) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4749575A (en) * | 1983-10-03 | 1988-06-07 | Bio-Dar Ltd. | Microencapsulated medicament in sweet matrix |
WO2005038968A2 (en) * | 2003-10-20 | 2005-04-28 | Catharina Philippina Janssen | Suspension for the generation of a current of electrons and the use and the preparation thereof |
CN110331138A (zh) * | 2019-06-29 | 2019-10-15 | 南京永正生物科技有限公司 | 一种生物复合酶微胶囊的生产工艺 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1183574B (it) * | 1985-05-08 | 1987-10-22 | Eurand Spa | Metodo per ottenere una sospensione estemporanea omogenea di microcapsule |
US4780320A (en) * | 1986-04-29 | 1988-10-25 | Pharmetrix Corp. | Controlled release drug delivery system for the periodontal pocket |
US4915948A (en) * | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
SE8705136D0 (sv) * | 1987-12-22 | 1987-12-22 | Pharmacia Ab | Oral doseringsenhet for lekemedel och dess anvendning och framstellning |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1444694A (fr) * | 1963-12-11 | 1966-07-08 | Ncr Co | Procédé de mise en capsules de l'acide acétylsalicylique |
FR1532740A (fr) * | 1966-07-22 | 1968-07-12 | Ncr Co | Procédé de préparation de microcapsules |
CH498653A (fr) * | 1968-03-29 | 1970-11-15 | Kobayashi Takehiko | Procédé d'encapsulation de matières hydrophobes |
-
1970
- 1970-02-06 FR FR7004199A patent/FR2077696B1/fr not_active Expired
-
1971
- 1971-01-22 ES ES387532A patent/ES387532A1/es not_active Expired
- 1971-02-03 NL NL7101418A patent/NL7101418A/xx not_active Application Discontinuation
- 1971-02-04 DE DE19712105110 patent/DE2105110A1/de active Pending
- 1971-02-05 BE BE762574A patent/BE762574A/xx unknown
- 1971-04-19 GB GB1297221D patent/GB1297221A/en not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4749575A (en) * | 1983-10-03 | 1988-06-07 | Bio-Dar Ltd. | Microencapsulated medicament in sweet matrix |
WO2005038968A2 (en) * | 2003-10-20 | 2005-04-28 | Catharina Philippina Janssen | Suspension for the generation of a current of electrons and the use and the preparation thereof |
WO2005038968A3 (en) * | 2003-10-20 | 2005-06-02 | Catharina Philippina Janssen | Suspension for the generation of a current of electrons and the use and the preparation thereof |
CN110331138A (zh) * | 2019-06-29 | 2019-10-15 | 南京永正生物科技有限公司 | 一种生物复合酶微胶囊的生产工艺 |
Also Published As
Publication number | Publication date |
---|---|
ES387532A1 (es) | 1974-12-16 |
NL7101418A (uk) | 1971-08-10 |
FR2077696B1 (uk) | 1973-03-16 |
FR2077696A1 (uk) | 1971-11-05 |
BE762574A (fr) | 1971-08-05 |
DE2105110A1 (de) | 1971-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1161439A (en) | Pharmaceutical Compositions | |
CA2166891A1 (en) | Method for making freeze dried drug dosage forms | |
GB1465781A (en) | Pharmaceutical preparations | |
IE812232L (en) | Composition | |
ES8608863A1 (es) | Un procedimiento para producir una composicion farmaceutica de un medicamento en forma de dosificacion unitaria de des- prendimiento prolongado | |
GB1465347A (en) | Composition | |
GB1346739A (en) | Veterinary medicinal compositions | |
IL41784A0 (en) | Novel optically active derivatives of 1-phenyl-2-aminoethanol,their preparation and pharmaceutical compositions containing them | |
GB1446352A (en) | Pharmaceutical compositions | |
GB1297221A (uk) | ||
HU173416B (hu) | Sposob poluchenija proizvodnykh p-aril/alkil/- ili alkenil-amino-benzojjnojj kisloty i lechebnykh preparatov soderzhahhikh takie aktivnye vehhestva | |
GB1445995A (en) | Pharmaceutical preparations comprising n-4-2-5-chloro-2-metho xybenzamidoethyl-phenylsulphonyl-n-cyclohexylurea and salts thereof | |
IL35987A0 (en) | Vitamin a acid amides,their preparation and pharmaceutical compositions containing them | |
JPH02502645A (ja) | 医薬用の経口投与量ユニツトおよびそれらの使用および製造 | |
EP0310126A3 (en) | Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines | |
GB1302266A (uk) | ||
ES8702140A1 (es) | Un procedimiento para la preparacion de una composicion de etoposido en forma de dosis unitaria para administracion oral | |
GB1327560A (en) | Effervescent pharmaceutical preparations | |
CA1024988A (en) | Derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them | |
GB1292241A (en) | Pharmaceutical preparations | |
GB1235540A (en) | Oral preparations containing proteolytic enzymes suitable for pediatric use | |
GB1153014A (en) | Improvements in or relating to An Oral Dose for the Treatment of Tuberculosis | |
IL43284A0 (en) | New derivatives of 3-amino-5-sulfamoyl-benzoic acid,their manufacture and pharmaceutical preparations containing the | |
EG10288A (en) | Process for the production of new derivatives of indolyl-acetic acid as active substance in drugs,used for inflamation sedatives and antipyrtic | |
GB1305179A (uk) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |